Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting1 award10 criteria
Montreal, Quebec
This trial is testing whether adding cryo-activation to ICB in advanced NSCLC will help the ICB work better.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.